Fecal and urinary incontinence
Conditions
Interventions
Transanal high-intensity focused ultrasound (HIFU) therapy
Sponsors
Suzuki Proctology-Moriguchi Internal Medicine Clinic
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Evaluation of fecal incontinence using the Wexner score (Cleveland Clinic Florida Fecal Incontinence Score: CCFIS) performed before treatment and within 3 months after treatment. Evaluation of urinary incontinence using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) performed before treatment and within 3 months after treatment. Written informed consent for participation in the clinical study obtained after treatment.
Exclusion criteria
Exclusion criteria: Concomitant use of other treatments for incontinence. Missing evaluation scores (Wexner score or ICIQ-SF). Loss to follow up after treatment. Cases in which patients consented to the procedure but did not provide written informed consent for participation in the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate changes in the severity of fecal and urinary incontinence before and after treatment using the Wexner score and the ICIQ-SF score (within 3 months after treatment). | — |
Countries
Japan
Contacts
Public ContactShunsuke Suzuki
Suzuki Proctology-Moriguchi Internal Medicine Clinic Suzuki Proctology-Moriguchi Internal Medicine Clinic
Outcome results
None listed